在海中进行的抗菌药物动力学研究:一篇综述
Eric F Egelund1,2, Alana Jula1, Kathleen Rish1
1Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Jacksonville, Florida, USA.
Journal of veterinary pharmacology and therapeutics
|November 12, 2024
概括
海面临着人类活动带来的威胁,导致感染. 了解抗微生物药理动力学对于这些脆弱的海洋动物的有效治疗和剂量至关重要.
科学领域:
- 海洋生物学 海洋生物学
- 兽医药理学 兽医药理学 兽医药理学
- 保存医学是一种保存医学.
背景情况:
- 海受到污染和气候变化等人类活动的威胁.
- 海受伤和生病会增加它们对感染的易感性.
- 有效的抗微生物治疗需要了解海的药物行为.
研究的目的:
- 对海中抗微生物药物的现有药理动力学研究进行审查.
- 为海治疗提供适当的抗菌剂剂量策略提供信息.
- 突出海抗微生物药理学方面的知识差距.
主要方法:
- 出版的药理动力学研究的文献综述.
- 对海的抗微生物特性和疗效的分析.
- 综合有关药物吸收,分布,新陈代谢和分泌的数据.
主要成果:
- 对于海中的抗微生物药物的药理动力学数据有限.
- 海生理学的变化会影响药物处置.
- 需要进一步的研究来建立可靠的剂量方案.
结论:
- 药物动力学数据对于在海中安全有效地使用抗微生物药物至关重要.
- 目前的知识不足以建立基于证据的治疗方案.
- 优先考虑药物动力学研究将有助于海的保护和健康.
更多相关视频
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
14.6K
16:02Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
2.6K
相关概念视频
01:28Antimicrobial Effectiveness
2
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
32
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
32